Explorer les evidences

23,4 %In the study, 23.4% of the 801 students in four secondary schools in Benin City, Nigeria, received the HPV vaccine.

Nigeriainfection à HPVpublié 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 10 observations

7 700 000 girlsIn October 2023, Nigeria integrated the single-dose human papillomavirus (HPV) vaccine into its routine immunization program, aiming to protect 7.7 million girls aged 9 to 14 years.

Nigeriainfection à HPVobservé October 2023publié 2024Cancer prevention research (Philadelphia, Pa.)PubMed

40,1 %Concern about the safety of the HPV vaccine was reported as a barrier by 40.1% of female undergraduates in a university in Ekiti State, southwest Nigeria.

Nigeriainfection à HPVpublié 2023African journal of reproductive healthPubMeddocument de 5 observations

36,2 %36.2% of the participants recognized that HPV can be transmitted via skin-to-skin contact.

Nigeriainfection à HPVpublié 2024BMC public healthPubMeddocument de 12 observations

hrHPV infection was defined as detection of at least one carcinogenic HPV genotype in a sample provided at the baseline visit.

NigeriahrHPV · infection à HPVpublié 2020BMC medical geneticsPubMeddocument de 6 observations

6 HPV_typesAmong these 25 HPV types in Nigeria, only six were included in the current nine-valent HPV vaccine.

Nigeriainfection à HPVpublié 2023Virology journalPubMeddocument de 8 observations

31,15 %Among the PCR-confirmed HPV types, 31.15% were undetermined HPV types.

Nigeriainfection à HPVpublié 2023Virology journalPubMeddocument de 8 observations

82,1 %Awareness of HPV-associated anal cancer was 82.1% among the participants.

Nigeriaanal cancer · infection à HPVpublié 2025Sexual healthPubMeddocument de 9 observations

53 %Inadequate awareness about the HPV vaccine was reported as a barrier by 53.0% of female undergraduates in a university in Ekiti State, southwest Nigeria.

Nigeriainfection à HPVpublié 2023African journal of reproductive healthPubMeddocument de 5 observations

24 %The prevalence of any HPV infection was 24% in the oral cavity among female sex workers in Ibadan, Nigeria.

Nigeriainfection à HPVpublié 2022PloS oneeurope_pmcdocument de 4 observations

3 casesThree mothers living with HIV had received HPV vaccination.

Nigeriainfection à HPVpublié 2026BMC public healthPubMeddocument de 8 observations

15,8 %Awareness of HPV-associated penile cancer was 15.8% among the participants.

Nigeriainfection à HPV · penile cancerpublié 2025Sexual healthPubMeddocument de 9 observations

100 %All the respondents had heard of HPV vaccine.

Nigeriainfection à HPVpublié 2024Reproductive healthPubMeddocument de 16 observations

12 %Among 213 women aged 16 to 63 years recruited in Lagos, Nigeria, 26 out of 213 participants had discordant HPV test results, representing 12% of total participants.

Nigeriainfection à HPVobservé 2020publié 2022BMC public healthPubMeddocument de 5 observations

20,8 %Among HPV-positive individuals, 20.8% had dual infections.

Nigeriainfection à HPVpublié 2019PloS onePubMeddocument de 7 observations

0 %Vaccination uptake among adolescents aged 9–14 years increased from 0% to 5.4%, with statistical significance (p < 0.0001).

Nigeriainfection à HPVpublié 2026Journal of the International AIDS SocietyPubMeddocument de 5 observations

37 %The pooled prevalence of cervical papillomavirus infection was 37% among women living with HIV/AIDS in Nigeria.

Nigeriainfection à HPVpublié 2020Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 2 observations

21 %Following a positive HPV result, 21% of women referred completed triage examination.

Nigeriainfection à HPVobservé 2021publié 2023BMC public healthPubMeddocument de 12 observations

29 cases29 out of 507 mothers living with HIV were informed about the HPV vaccine.

Nigeriainfection à HPVpublié 2026BMC public healthPubMeddocument de 8 observations

56,3 %In the study, 56.3% of refusals for the HPV vaccine were due to fear of side effects among students in four secondary schools in Benin City, Nigeria.

Nigeriainfection à HPVpublié 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 10 observations

54,1 %Overall HPV prevalence was 54.1% among a cohort of 220 HIV-infected women attending the antiretroviral clinic of the Federal Medical Centre, Keffi, Nigeria.

Nigeriainfection à HPVpublié 2019The Pan African medical journalPubMeddocument de 5 observations

50,9 %50.9% of the participants acknowledged that early sexual debut increases the risk of acquiring HPV.

Nigeriainfection à HPVpublié 2024BMC public healthPubMeddocument de 12 observations

97,6 %Most entries (42/43, 97.6%) focused on cervical cancer and human papillomavirus.

Nigeriacancer du col de l'utérus · infection à HPVpublié 2026JMIR formative researchPubMeddocument de 7 observations

93,6 %Among 249 sexual minority men living with HIV in Abuja, Nigeria, 93.6% reported willingness to receive HPV vaccine.

Nigeriainfection à HPVpublié 2026Sexual healthPubMeddocument de 6 observations

32,7 %HPV vaccine acceptance ranged from 32.7% to 97.3% in studies conducted in Nigeria.

Nigeriainfection à HPVpublié 2026BMC public healthPubMeddocument de 3 observations